Abstract
PD-1/PD-L1-based therapy has been named a revolution in cancer treatment. By the end of 2018, more than 100 anti-PD-1 and anti-PD-L1 antibodies were i......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
